Loss of Heterozygosity (LOH) Affecting HLA Genes in Breast Cancer
Author Information
Author(s): Garrido María Antonia, Navarro-Ocón Alba, Ronco-Díaz Víctor, Olea Nicolás, Aptsiauri Natalia
Primary Institution: Virgen de la Nieves University Hospital
Hypothesis
The study investigates the role of loss of heterozygosity (LOH) at HLA genes in breast cancer and its implications for immune evasion and treatment resistance.
Conclusion
LOH at chromosome 6, which includes HLA genes, is common in breast cancer and is associated with poor prognosis and resistance to immunotherapy.
Supporting Evidence
- LOH-HLA is linked to cancer progression and a weak response to immunotherapy.
- Breast cancer cells often downregulate HLA class-I expression, making them less visible to the immune system.
- High levels of HLA-I expression are associated with better survival rates in breast cancer patients.
Takeaway
Some breast cancer cells lose important genes that help the immune system recognize and fight them, making it harder to treat the cancer.
Methodology
The review discusses various studies on LOH in HLA genes and its impact on breast cancer progression and treatment outcomes.
Limitations
The review is based on existing literature and may not include all recent findings or data from ongoing studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website